{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:49:55Z","timestamp":1779281395471,"version":"3.51.4"},"reference-count":37,"publisher":"American Society of Hematology","issue":"24","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>The recognition of B-cell prolymphocytic leukemia (B-PLL) as a separate entity is controversial based on the current classification systems. Here, we analyzed the DNA methylome of a cohort of 20 B-PLL cases diagnosed according to the guidelines of the International Consensus Classification\/Fourth revised edition of the World Health Organization Classification, and compared them with chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), splenic marginal zone lymphoma (SMZL), and normal B-cell subpopulations. Unsupervised principal component analyses suggest that B-PLL is epigenetically distinct from CLL, MCL, and SMZL, which is further supported by robust differential methylation signatures in B-PLL. We also observe that B-PLL can be segregated into 2 epitypes with differential clinicobiological characteristics. B-PLL epitype 1 carries lower immunoglobulin heavy variable somatic hypermutation and a less profound germinal center\u2013related DNA methylation imprint than epitype 2. Furthermore, epitype 1 is significantly enriched in mutations affecting MYC and SF3B1, and displays DNA hypomethylation and gene upregulation signatures enriched in MYC targets. Despite the low sample size, patients from epitype 1 have an inferior overall survival than those of epitype 2. This study provides relevant insights into the biology and differential diagnosis of B-PLL, and potentially identifies 2 subgroups with distinct biological and clinical features.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024013327","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T21:37:28Z","timestamp":1730237848000},"page":"6297-6307","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-231X","authenticated-orcid":false,"given":"Stella","family":"Charalampopoulou","sequence":"first","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3427-7596","authenticated-orcid":false,"given":"Elise","family":"Chapiro","sequence":"additional","affiliation":[{"name":"2Service d'H\u00e9matologie Biologique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"3Centre de Recherche des Cordeliers, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-9440","authenticated-orcid":false,"given":"Ferran","family":"Nadeu","sequence":"additional","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-9845","authenticated-orcid":false,"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[{"name":"5Department of Medical Oncology and Hematology, University Hospital and University of Z\u00fcrich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2385","authenticated-orcid":false,"given":"S\u00edlvia","family":"Be\u00e0","sequence":"additional","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"6Pathology Department, Hematopathology Section, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"7Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ares","family":"Mart\u00ednez-Farran","sequence":"additional","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6263-1682","authenticated-orcid":false,"given":"Marta","family":"Aymerich","sequence":"additional","affiliation":[{"name":"6Pathology Department, Hematopathology Section, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2641-1110","authenticated-orcid":false,"given":"Maria","family":"Rozman","sequence":"additional","affiliation":[{"name":"6Pathology Department, Hematopathology Section, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-755X","authenticated-orcid":false,"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[{"name":"2Service d'H\u00e9matologie Biologique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"3Centre de Recherche des Cordeliers, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bernard","sequence":"additional","affiliation":[{"name":"8Gustave Roussy, INSERN U1170, Villejuif, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-1628","authenticated-orcid":false,"given":"Santos A.","family":"Susin","sequence":"additional","affiliation":[{"name":"3Centre de Recherche des Cordeliers, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-9781","authenticated-orcid":false,"given":"Helen","family":"Parker","sequence":"additional","affiliation":[{"name":"9Cancer Genomics, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Walewska","sequence":"additional","affiliation":[{"name":"10Department of Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Oakes","sequence":"additional","affiliation":[{"name":"11Division of Hematology, The Ohio State University, Columbus, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-2881","authenticated-orcid":false,"given":"Jonathan C.","family":"Strefford","sequence":"additional","affiliation":[{"name":"9Cancer Genomics, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"4Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer, Madrid, Spain"},{"name":"6Pathology Department, Hematopathology Section, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"},{"name":"7Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Matutes","sequence":"additional","affiliation":[{"name":"6Pathology Department, Hematopathology Section, Hospital Cl\u00ednic de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-5819","authenticated-orcid":false,"given":"Mart\u00ed","family":"Duran-Ferrer","sequence":"additional","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3107-6668","authenticated-orcid":false,"given":"Florence","family":"Nguyen-Khac","sequence":"additional","affiliation":[{"name":"2Service d'H\u00e9matologie Biologique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Sorbonne Universit\u00e9, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"},{"name":"3Centre de Recherche des Cordeliers, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9, INSERM UMRS 1138, Drug Resistance in Hematological Malignancies Team, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5195","authenticated-orcid":false,"given":"Jos\u00e9 I.","family":"Mart\u00edn-Subero","sequence":"additional","affiliation":[{"name":"1Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"},{"name":"7Departament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain"},{"name":"12Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"6","key":"2024122319355995800_bib1","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3324\/haematol.2022.282162","article-title":"Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)","volume":"108","author":"Algrin","year":"2023","journal-title":"Haematologica"},{"issue":"2","key":"2024122319355995800_bib2","first-page":"233","article-title":"Prolymphocytic leukaemia of B and T cell type","author":"Catovsky","year":"1973","journal-title":"Lancet"},{"issue":"1","key":"2024122319355995800_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1974.tb06769.x","article-title":"Prolymphocytic leukaemia","volume":"27","author":"Galton","year":"1974","journal-title":"Br J Haematol"},{"key":"2024122319355995800_bib4","first-page":"131","volume-title":"WHO Classification of Tumours - Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue","author":"Catovsky","year":"2001"},{"issue":"21","key":"2024122319355995800_bib5","first-page":"1821","article-title":"Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53","volume":"134","author":"Chapiro","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2024122319355995800_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41375-023-01821-3","article-title":"The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","volume":"37","author":"Nguyen-Khac","year":"2023","journal-title":"Leukemia"},{"issue":"5","key":"2024122319355995800_bib7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41375-023-01872-6","article-title":"Response to the comments from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors","volume":"37","author":"Siebert","year":"2023","journal-title":"Leukemia"},{"issue":"7","key":"2024122319355995800_bib8","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"2024122319355995800_bib9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"2024122319355995800_bib10","author":"Swerdlow","year":"2017","edition":"Revised 4th ed"},{"key":"2024122319355995800_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-pathmechdis-051122-100856","article-title":"Epigenomic characterization of lymphoid neoplasms","volume":"19","author":"Duran-Ferrer","year":"2024","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"2024122319355995800_bib12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat Genet"},{"issue":"3","key":"2024122319355995800_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat Genet"},{"issue":"3","key":"2024122319355995800_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/bjh.18465","article-title":"Integrative epigenomics in chronic lymphocytic leukaemia: biological insights and clinical applications","volume":"200","author":"Kulis","year":"2023","journal-title":"Br J Haematol"},{"issue":"5","key":"2024122319355995800_bib15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ccell.2016.09.014","article-title":"Decoding the DNA methylome of mantle cell lymphoma in the light of the entire B cell lineage","volume":"30","author":"Queir\u00f3s","year":"2016","journal-title":"Cancer Cell"},{"issue":"5","key":"2024122319355995800_bib16","first-page":"585","article-title":"Identification of 2 DNA methylation subtypes of Waldenstr\u00f6m macroglobulinemia with plasma and memory b-cell features","volume":"136","author":"Roos-Weil","year":"2020","journal-title":"Blood"},{"issue":"12","key":"2024122319355995800_bib17","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood-2014-08-596247","article-title":"DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features","volume":"125","author":"Arribas","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2024122319355995800_bib18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s43018-020-00131-2","article-title":"The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome","volume":"1","author":"Duran-Ferrer","year":"2020","journal-title":"Nat Cancer"},{"issue":"9","key":"2024122319355995800_bib19","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.3324\/haematol.2020.253062","article-title":"Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?","volume":"105","author":"Magnano","year":"2020","journal-title":"Haematologica"},{"issue":"9","key":"2024122319355995800_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3324\/haematol.2016.160374","article-title":"Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier","volume":"102","author":"Navarro","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"2024122319355995800_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41467-020-20849-y","article-title":"Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation","volume":"12","author":"Vilarrasa-Blasi","year":"2021","journal-title":"Nat Commun"},{"issue":"7574","key":"2024122319355995800_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"12","key":"2024122319355995800_bib23","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"issue":"11","key":"2024122319355995800_bib24","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat Genet"},{"issue":"1","key":"2024122319355995800_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/bjh.19064","article-title":"Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology Guideline","volume":"204","author":"Walewska","year":"2024","journal-title":"Br J Haematol"},{"issue":"1","key":"2024122319355995800_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI93801","article-title":"Drug-perturbation-based stratification of blood cancer","volume":"128","author":"Dietrich","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"2024122319355995800_bib27","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"issue":"7","key":"2024122319355995800_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ng.3291","article-title":"Whole-genome fingerprint of the DNA methylome during human B cell differentiation","volume":"47","author":"Kulis","year":"2015","journal-title":"Nat Genet"},{"issue":"7345","key":"2024122319355995800_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature09906","article-title":"Mapping and analysis of chromatin state dynamics in nine human cell types","volume":"473","author":"Ernst","year":"2011","journal-title":"Nature"},{"issue":"3","key":"2024122319355995800_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.2004.04913.x","article-title":"B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia","volume":"125","author":"Ruchlemer","year":"2004","journal-title":"Br J Haematol"},{"issue":"9","key":"2024122319355995800_bib31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D12 mantle cell lymphoma","volume":"133","author":"Mart\u00edn-Garcia","year":"2019","journal-title":"Blood"},{"issue":"8","key":"2024122319355995800_bib32","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.3324\/haematol.2019.237073","article-title":"Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma","volume":"105","author":"Fuster","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"2024122319355995800_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41467-022-34642-6","article-title":"Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis","volume":"14","author":"Bros\u00e9us","year":"2023","journal-title":"Nat Commun"},{"key":"2024122319355995800_bib34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2147\/IJGM.S307367","article-title":"Expression analysis of MIST1 and EMT markers in primary tumor samples points to MIST1 as a biomarker of cervical cancer","volume":"14","author":"Wang","year":"2021","journal-title":"Int J Gen Med"},{"issue":"1","key":"2024122319355995800_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"issue":"17","key":"2024122319355995800_bib36","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2024122319355995800_bib37","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/leu.2013.98","article-title":"Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2","volume":"27","author":"Strefford","year":"2013","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/24\/6297\/2347175\/blooda_adv-2024-013327-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/24\/6297\/2347175\/blooda_adv-2024-013327-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T19:36:17Z","timestamp":1734982577000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/24\/6297\/525814\/Epigenetic-features-support-the-diagnosis-of-B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":37,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,12,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013327","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}